Welcome to the HIV/AIDS Prevention Research Division

The mission of the HIV/AIDS Prevention Research Division is to develop and evaluate interventions designed to reduce the spread of HIV and other blood-borne infections. The division promotes the application of evidence-based practices in the development of public health policies to respond to the HIV epidemic.

 



Publications

Mobile Units for Integrated Addiction and HIV Prevention Services for People Who Inject Drugs: The HPTN 094 Randomized Clinical Trial

JAMA Psychiatry. 2026 Nov 4:e263644. doi: 10.1001/jamapsychiatry.2026.3644. Online ahead of print.

ABSTRACT

IMPORTANCE: Integrated models to deliver HIV preexposure prophylaxis (PrEP) and medication for opioid use disorder (MOUD) for people who inject drugs are needed.

OBJECTIVE: To determine whether integrated PrEP and MOUD services delivered on a mobile unit with manualized peer navigation improved PrEP and MOUD use compared with peer navigation to existing community-based…


CONCLUSIONS AND RELEVANCE: In this randomized clinical trial, mobile delivery of integrated HIV prevention, addiction, and navigation services did not improve primary outcomes beyond peer navigation alone. The significantly lower all-cause death rate at 52 weeks in the intervention arm bears replication for delivering integrated PrEP and MOUD services to people who inject drugs.

Extended in vivo activity of VRC01 HIV-1 prophylaxis entails initial protective efficacy and subsequent breakthrough infections

Sci Transl Med. 2026 Nov 4;18(874):eaec3480. doi: 10.1126/scitranslmed.aec3480. Epub 2026 Nov 4.

ABSTRACT

The two parallel antibody-mediated prevention (AMP) efficacy trials evaluated whether intravenous infusion of the anti-CD4 binding site broadly neutralizing antibody VRC01 prevents HIV-1 acquisition. Here, we analyzed HIV-1 acquisition in AMP through the week 104 final study visit. Against viruses considered highly sensitive to VRC01 [80% inhibitory concentration (IC80) <…


The two parallel antibody-mediated prevention (AMP) efficacy trials evaluated whether intravenous infusion of the anti-CD4 binding site broadly neutralizing antibody VRC01 prevents HIV-1 acquisition. Here, we analyzed HIV-1 acquisition in AMP through the week 104 final study visit. Against viruses considered highly sensitive to VRC01 [80% inhibitory concentration (IC(80))

Association between Trust and Patient-Reported Outcomes and Experience in Prostate Cancer Patients

Med Decis Making. 2026 Oct 15:272989X261493550. doi: 10.1177/0272989X261493550. Online ahead of print.

ABSTRACT

PURPOSE: To evaluate the association between patient-physician trust, treatment choice, patient-reported outcomes, and patient-reported experiences among patients with localized prostate cancer.

MATERIALS AND METHODS: We conducted a secondary analysis of data from a multicenter randomized controlled trial among patients with localized prostate cancer. Trust was measured at baseline, prior to treatment, using…


CONCLUSIONS: Higher patient-physician trust was independently associated with treatment choice, patient-reported outcomes, and patient-reported experience. These findings underscore the importance of patient-physician trust as a component of patient-centered cancer care and shared decision making. Future studies should evaluate interventions designed to strengthen trust and improve patient-centered outcomes across diverse clinical settings.

Service-Level Utilization in Risk-Based Contracts and a Benchmarking Approach for Fee-Schedule Reforms

JAMA Health Forum. 2026 Oct 2;7(10):e263533. doi: 10.1001/jamahealthforum.2026.3533.

ABSTRACT

IMPORTANCE: Despite revived interest in reforming the physician fee schedule, it is unclear how policymakers should modify more than 1000 different physician service prices to promote high-value care. One systematic approach could leverage service-level utilization patterns in full-risk contracts, which have not been previously characterized.

OBJECTIVE: To compare service-level utilization patterns between health care professional organizations…


CONCLUSION AND RELEVANCE: In this cross-sectional study, the association between risk-based contracts and service utilization varied substantially across 1271 individual services. Service-specific utilization levels in risk-based contracts may serve as a benchmark to guide reforms to fee-for-service prices.

Just4Us: Acceptability and Feasibility of a Woman-Focused Pre-exposure Prophylaxis (PrEP) Randomized Controlled Trial Intervention

Arch Sex Behav. 2026 Jul;55(7):3273-3286. doi: 10.1007/s10508-026-03524-z. Epub 2026 Sep 30.

ABSTRACT

Women comprise 19% of new HIV infections in the USA. Many women, particularly women of color, are unaware of pre-exposure prophylaxis (PrEP) as an HIV prevention option. We conducted a pilot randomized controlled trial to assess feasibility and acceptability of a theory-based, contextually relevant behavioral intervention, Just4Us, to promote PrEP initiation and adherence…


Women comprise 19% of new HIV infections in the USA. Many women, particularly women of color, are unaware of pre-exposure prophylaxis (PrEP) as an HIV prevention option. We conducted a pilot randomized controlled trial to assess feasibility and acceptability of a theory-based, contextually relevant behavioral intervention, Just4Us, to promote PrEP initiation and adherence among women in New York City and Philadelphia. Eligibility criteria included: cisgender…

Association between retention in HIV care, psychiatric comorbidities, and outcomes in veterans with HIV

J Acquir Immune Defic Syndr. 2026 Sep 4. doi: 10.1097/QAI.0000000000003966. Online ahead of print.

ABSTRACT

BACKGROUND: In the US, the Veterans Health Administration is the largest single institutional provider of Human Immunodeficiency Virus (HIV) care for veterans. Retention in care can affect treatment adherence and care outcomes. Psychiatric disorders are prevalent in people with HIV and may lead to poorer retention in care and outcomes.…


CONCLUSIONS: Our study provides important insights into the relationship between retention in care, psychiatric comorbidity, and outcomes in veterans with HIV. Future research must assess the barriers to care and strategies to integrate mental health and HIV treatments for veterans.

"Delivering High-Quality Care in This Setting Requires a Lot of Resources": HPTN 094 Implementation Lessons From Delivering Integrated HIV and MOUD Care Through Mobile Units in Local Neighborhoods

J Acquir Immune Defic Syndr. 2026 Dec 1;101(12):1363-1372. doi: 10.1097/QAI.0000000000003947.

ABSTRACT

BACKGROUND: The HIV Prevention Trials Network 094 INTEGRA study sought to fill the gap in implementation science literature by exploring the delivery of integrated prevention and care for HIV and opioid use dependence through mobile units to people who inject drugs (PWID).

SETTING: Five US INTEGRA sites with diverse implementation landscapes that were disproportionately…


CONCLUSIONS: Findings demonstrated that mobile integrated care models can reduce access barriers for PWID but require tailored implementation strategies to address operational, spatial, infrastructural, and community-level demands. Results may help inform an implementation blueprint for similar communities working to respond to the intersecting HIV and opioid epidemics affecting PWID across US settings.

Reproductive health considerations for HIV prevention integrated care models for women who inject drugs: Qualitative perspective of participants and providers in HIV Prevention Trials Network 094

Drug Alcohol Depend. 2026 Sep 1;286:113266. doi: 10.1016/j.drugalcdep.2026.113266. Epub 2026 Jul 15.

ABSTRACT

BACKGROUND: Cisgender women who inject drugs (WWID) face gendered health inequities and unique barriers to accessing healthcare services. We explored WWID's sexual and reproductive health (SRH) needs to inform the development of integrated care for this population.

METHODS: The HPTN 094 (INTEGRA) study tested the efficacy of delivering mobile integrated services for…


BACKGROUND: Cisgender women who inject drugs (WWID) face gendered health inequities and unique barriers to accessing healthcare services. We explored WWID's sexual and reproductive health (SRH) needs to inform the development of integrated care for this population.

Perceptions of Buprenorphine With Naloxone Treatment and the Fear of Precipitated Withdrawal: A Qualitative Exploration With HIV Prevention Trials Network 094 INTEGRA Participants and Staff

Drug Alcohol Rev. 2026 Jul;45(5):e70198. doi: 10.1111/dar.70198.

ABSTRACT

INTRODUCTION: Uptake of evidence-based medication for opioid use disorder (MOUD), including buprenorphine-naloxone, remains low despite the expanding US opioid crisis. This study examined participants' and staff perceptions of adopting and delivering buprenorphine-naloxone on a mobile unit providing integrated MOUD and HIV services for people with opioid use disorder who inject drugs in the HPTN 094 INTEGRA trial.…


INTRODUCTION: Uptake of evidence-based medication for opioid use disorder (MOUD), including buprenorphine-naloxone, remains low despite the expanding US opioid crisis. This study examined participants' and staff perceptions of adopting and delivering buprenorphine-naloxone on a mobile unit providing integrated MOUD and HIV services for people with opioid use disorder who inject drugs in the HPTN 094 INTEGRA trial.

Determining the minimal important change of the abdominal Hernia-Q

Hernia. 2026 May 12;30(1):202. doi: 10.1007/s10029-026-03645-3.

ABSTRACT

PURPOSE: The Abdominal Hernia-Q(AHQ) is a validated PRO tool for hernia patients. This study aimed to determine the Minimal Important Change (MIC) for the AHQ, examining changes in AHQ scores and exploring associations with key clinical characteristics.

METHODS: A retrospective cohort design was used. Patients who underwent hernia repair between January 2017 and January 2022 and completed the…


CONCLUSION: The findings suggest that patients with worse preoperative status may still experience clinically significant benefits. Establishing the MIC for the AHQ may enable the identification of patients likely to experience significant improvements in quality of life after hernia repair.

DNA electroporation of HIV Env elicits robust T cell responses and memory B cell responses with muted serum antibody levels that can be boosted with recombinant protein

Vaccine. 2026 Apr 19;79:128487. doi: 10.1016/j.vaccine.2026.128487. Epub 2026 Mar 21.

ABSTRACT

Broadly neutralizing antibodies against the HIV envelope protein exhibit the potential to prevent HIV-1 acquisition, a concept demonstrated both in non-human primate (NHP) challenge models and in human clinical trials. The use of DNA for vaccination, in combination with IL-12 and delivered via intradermal (ID)-adaptive electroporation (EP), has resulted in excellent cellular and humoral…


Broadly neutralizing antibodies against the HIV envelope protein exhibit the potential to prevent HIV-1 acquisition, a concept demonstrated both in non-human primate (NHP) challenge models and in human clinical trials. The use of DNA for vaccination, in combination with IL-12 and delivered via intradermal (ID)-adaptive electroporation (EP), has resulted in excellent cellular and humoral immunogenicity. HVTN 304 (NCT05828095) is a first-in-human, phase 1 clinical trial…

Distinct Antibody Fc-profiles in Lymph During Homeostasis and Chronic HIV Infection

Pathog Immun. 2026 Feb 23;11(1):111-134. doi: 10.20411/pai.v11i1.887. eCollection 2026.

ABSTRACT

BACKGROUND: Antibodies play a critical role in the control of pathogens and tumors through their ability to recognize non-self and then direct immune-mediated destruction. Antibodies are generated by plasma cells or plasmablasts, located throughout the tissues, and are transported between blood, lymph, mucosal secretions, and tissues to survey all sites for pathogens or malignant cells.…


CONCLUSION: Differential transfer of IgG was Fc-receptor dependent, pointing to a mechanism of transfer into tissues during inflammatory disease that may have a critical role in selecting the antibodies able to access the peripheral and lymphoid tissues.

Building Trust and Engaging Communities for HIV Prevention Research Globally

AIDS Educ Prev. 2026 Feb;38(1):1-17. doi: 10.1521/aeap.2026.38.1.1.

ABSTRACT

The HIV Vaccine Trials Network (HVTN) is the largest publicly funded international collaboration facilitating the evaluation of vaccines to prevent HIV and TB. Central to the HVTN's success is the reliance on robust community engagement methods, ensuring community participation and facilitating community awareness and knowledge of research. Community engagement is a dynamic process that requires active participation…


The HIV Vaccine Trials Network (HVTN) is the largest publicly funded international collaboration facilitating the evaluation of vaccines to prevent HIV and TB. Central to the HVTN's success is the reliance on robust community engagement methods, ensuring community participation and facilitating community awareness and knowledge of research. Community engagement is a dynamic process that requires active participation from all stakeholders to ensure success. The HVTN…

Prevalence of Illicit Drug Detection in 5 US Cities Among Out-of-Treatment People Who Inject Drugs

JAMA Netw Open. 2026 Feb 2;9(2):e2555882. doi: 10.1001/jamanetworkopen.2025.55882.

ABSTRACT

IMPORTANCE: In the US, the overdose crisis continues to be driven by fentanyl, xylazine, and stimulant-involved polysubstance use among people who inject drugs, especially those who are not engaged in medical care.

OBJECTIVE: To estimate the overall prevalence of illicit drugs detected among people who inject drugs in 5 US cities by city and sociodemographic characteristics…


CONCLUSIONS AND RELEVANCE: This cross-sectional study found widespread fentanyl and polysubstance detection, with rising xylazine and stimulant detection that varied by sociodemographic and structural vulnerabilities and may be due to adulteration within the unregulated drug supply. These findings highlight urgent public health needs for real-time drug supply surveillance, targeted harm-reduction services, and integrated treatment approaches to reduce overdose risk and address social and...

"I Want to Live: A Qualitative Investigation of Barriers and Facilitators to ART Adherence & Mental Health Maintenance in People With HIV"

J Int Assoc Provid AIDS Care. 2026 Jan-Dec;25:23259582251413665. doi: 10.1177/23259582251413665. Epub 2026 Jan 20.

ABSTRACT

ObjectiveMental health symptoms hinder engagement in antiretroviral therapy (ART) adherence among persons with HIV (PWH). Existing information on barriers and facilitators to mental health treatment in PWH is limited. This qualitative study explored barriers and facilitators to mental health treatment and ART adherence in PWH.MethodsPWH (n = 16) and…


ObjectiveMental health symptoms hinder engagement in antiretroviral therapy (ART) adherence among persons with HIV (PWH). Existing information on barriers and facilitators to mental health treatment in PWH is limited. This qualitative study explored barriers and facilitators to mental health treatment and ART adherence in PWH.MethodsPWH (n = 16) and health professionals (N = 6) completed semi-structured interviews.ResultsThree themes describe how and why barriers to care…